This bill amends the Uniform Controlled Substances Act in Nebraska by updating definitions and classifications of various substances, particularly focusing on synthetic and non-synthetic compounds. It introduces the term "7-Hyroxymitragynine," defining it based on its alkaloid composition, and adds several new substances, including various fentanyl analogs and synthetic opioids, to the controlled substances schedule. The bill also clarifies the definition of "lookalike substance" to better reflect products perceived as controlled substances, while correcting spelling errors in existing definitions and repealing outdated language.

Additionally, the bill proposes the addition of new substances such as Ethylphenidate and Dipentylone to Schedule I, along with a comprehensive list of narcotic drugs and their derivatives under Schedules II and III. It introduces new entries with depressant and stimulant effects, including Clonazolam and Flualprazolam, while removing references to Gamma-Hydroxybutyric Acid. The legislation aims to enhance the regulatory framework surrounding these substances to address public health concerns related to drug abuse and misuse, ensuring that any material intended for human consumption is adequately monitored.

Statutes affected:
Introduced: 28-401, 28-405